In lab experiments and animal models, UNC and NC State researchers led by Zhen Gu, PhD, designed synthetic beta cells to secrete insulin in response to high blood sugar.
Treating type 1 diabetes and some cases of type 2 diabetes has long required painful and frequent insulin injections or a mechanical insulin pump for insulin infusion. But researchers from the University of North Carolina and NC State have now developed what could be a much more patient-friendly option: artificial cells that automatically release insulin into the bloodstream when glucose levels rise.
These “artificial beta cells” (A?Cs) mimic the functions of the body’s natural glucose-controllers, the insulin-secreting beta cells of the pancreas. The loss or dysfunction of these cells causes type 1 diabetes and many cases of type 2 diabetes. The idea is that the A?Cs could be subcutaneously inserted into patients, which would be replaced every few days, or by a painless and disposable skin patch.
As the researchers report in Nature Chemical Biology, a single injection of the A?Cs into diabetic mice lacking beta cells quickly normalized the animals’ blood glucose levels and kept those levels normal for up to five days.
“Our plan now is to further optimize and test these synthetic cells in larger animals, develop a skin patch delivery system for them, and ultimately test them in people with diabetes,” said principal investigator Zhen Gu, PhD, a professor in the Joint UNC/NC State Department of Biomedical Engineering. Gu also holds appointments in the UNC School of Medicine, the UNC Eshelman School of Pharmacy, and the UNC Diabetes Care Center.
At least six million people in the United States use insulin as a diabetes treatment, either by injection or a mechanical pump. So far, delivered insulin in pill form has been challenging because it’s a large molecule that would be destroyed by digestive enzymes and acids before it could reach the bloodstream.
The major problem with current insulin treatments, however, is not that they can’t be delivered in a pill, but that they can’t control blood glucose levels automatically and efficiently, as normal insulin-secreting pancreatic cells do. Transplants of pancreatic cells can solve that problem in some cases. However, such cell transplants are expensive, require donor cells that are often in short supply, require immune-suppressing drugs, and often fail due to the destruction of the transplanted cells.
Gu and colleagues have been researching solutions to the insulin-delivery problem for much of the past decade. For this project, they adopted a particularly ambitious approach: making artificial cells that, to a great extent, do what natural pancreatic beta cells do.
Gu’s A?Cs are constructed with a simplified version of a normal cell’s two-layered lipid membrane. The key innovation is what these cells contain: specially designed, insulin-stuffed vesicles. A rise in blood glucose levels leads to chemical changes in the vesicle coating, causing the vesicles to start fusing with the A?C’s outer membrane – thus releasing the insulin payloads.
“This is the first demonstration using such a vesicle fusion process for delivering insulin that employs insulin-containing vesicles like those found in a beta cell and can reproduce the beta cell’s functions in sensing glucose and responding with insulin ’secretion’,” said Zhaowei Chen, PhD, a lead author and postdoctoral researcher in Gu’s lab.
The A?Cs showed a rapid responsiveness to excess glucose levels in lab-dish tests and in diabetic mice without beta cells. “The mice went from hyperglycemic to normoglycemic within an hour, and they remained normoglycemic for up to five days after that,” Gu said. Control mice injected with no-insulin A?Cs remained hyperglycemic.
Gu and colleagues plan further preclinical tests and expect to develop a method for delivering the cells painlessly via a skin patch that could be simply replaced.
Co-author John Buse, MD, PhD, the Verne S. Caviness Distinguished Professor at UNC, chief of the division of endocrinology, and director of the UNC Diabetes Care Center, said, “There is still much work needed to optimize this artificial-cell approach before human studies are attempted, but these results so far are a remarkable, creative first step to a new way to solve the diabetes problem using chemical engineering as opposed to mechanical pumps or living transplants.”
Gu and his team are also working separately on a cell-free skin patch, a “smart insulin patch” that senses blood glucose levels and secretes insulin into the bloodstream as needed.
The Latest on: Synthetic beta cells
[google_news title=”” keyword=”Synthetic beta cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Q4 2023 Fate Therapeutics Inc Earnings Callon February 27, 2024 at 12:07 am
These novel synthetic controls include a CXCR2 receptor to promote cell trafficking, a Chimera TGF beta receptor to redirect immunosuppressive signals in the tumor microenvironment, a high-affinity ...
- Best Steroid Alternatives for Muscle Growth - Closest Thing To Steroids Thats Legal for Bodybuildingon February 26, 2024 at 10:51 pm
Testimonials usually highlight the absence of side effects typically associated with synthetic steroids ... Trenorol contains natural ingredients such as beta-sitosterol, samento inner bark, nettle ...
- The Best Natural Face Washes for Menon February 26, 2024 at 7:58 am
Reviewed by Dr. Diana Rangaves, PharmD An effective skin-care routine starts with a high-quality face wash, and many men are choosing to go for nature-powered formulas made with premium ingredients.
- Infusion of Artificial Intelligence in Biologyon February 22, 2024 at 4:01 pm
That is what is really exciting about the field,” said Baker. There is always more work to be done. Proteins in cells are often part of macromolecular complexes. Current AI models work well for ...
- The multivitamins and supplements that really benefit your health.. and the right time to take them: Read our ultimate nutrient guideon February 22, 2024 at 3:55 am
The ingredients used can also vary — there are both natural and synthetic sources ... including immune-enhancing beta-glucans — soluble fibre found in the cell walls of bacteria, fungi, yeasts and ...
- First step towards synthetic CO2 fixation in living cellson February 20, 2024 at 4:00 pm
Three modules forming a new-to-nature CO 2 fixation cycle successfully implemented in E.coli “Bringing parts of the THETA cycle into living cells is an important proof-of-principle for synthetic ...
- Making Moves Toward Cell Therapy for Diabeteson February 19, 2024 at 4:00 pm
Previous transplant studies with diabetic rodent models suggested that progenitor cells may be adequate for mature beta cell function postimplantation. The quality control parameters highlighted along ...
- New treatments are emerging for type-1 diabeteson February 19, 2024 at 4:00 pm
The islets’ insulin producers are called beta cells. (Cell types alpha, gamma, delta and epsilon perform other tasks.) They are the only bodily sources of that hormone. So, if their number ...
- The Best Natural Skincare Products in 2024on February 19, 2024 at 1:14 pm
Branded content. Us Weekly has affiliate partnerships so we may receive compensation for some links to products and services. Reviewed by Dr. Diana Rangaves, PharmD Natural skin care products are all ...
- Alzheimer's Disease Can Be Transmitted From One Person To Another During Certain Medical Procedures, According To A New Studyon February 14, 2024 at 7:25 pm
Alzheimer’s disease is partially attributed to the slow buildup of amyloid-beta and tau proteins in the brain. This accumulation initiates a series of events culminating in the demise of brain cells .
via Google News and Bing News